Pilot corpus: NIH-funded biomedical datasets. Any DOI can be scored on demand — network effects sharpen as coverage grows.

Anticancer potential of (−)-epicatechin in a triple-negative mammary gland model

Journal of Pharmacy and Pharmacology(2021)10.1093/jpp/rgab133Source: DataRank Database

Anticancer potential of (−)-epicatechin in a triple-negative mammary gland model is a research paper published in Journal of Pharmacy and Pharmacology (2021). On theSindex it has a DataRank of 0. It has been cited 18 times.

N/A

0DataRank · unranked

Scored on demand from live citation data

Open Access18 citations

Download PDF

Cite:

DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?

›Methodology & internals

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Pipeline:MetadataData-paper checkEnrichmentCitation networkScoring

Enrichment:Funding (5 grants)Impact (FWCI 0.67)OA: greenTopics (88)IDs (PubMed, PMC, OpenAlex)SDGs (2)

FAIR Checklist

Context only (not used in score)

Findable (1/2)

Has DOI

Accessible (1/2)

Open Access

Interoperable (0/2)

Reusable (0/3)

FAIR checklist signals are shown for context only and do not affect DataRank scoring.

Run a calibrated FAIR evaluation for this paper →

We only score data papers we can read in full — never from an abstract alone.

Authors (9)

Pilar Ortiz-Vilchis ORCID,P Cordero,Rocío Martinez-Vega,Javier Pérez‐Durán ORCID,Eduardo Meaney

Live enrichment

PubMed:34473289 PMC:PMC8651247 OpenAlex:https://openalex.org/W3197503074

NIH HHS

Grant: NIH DK98717

NIDDK NIH HHS

Grant: R01 DK098717

NIA NIH HHS

Grant: R21 AG047326

National Institutes of Health

Grant: AG47326

National Institutes of Health

Grant: 5R01DK098717-03

Epicatechin and derivatives to preserve muscle structure function in diabetes

FWCI

0.67

Citation Percentile

0.7%

Citation Trend

2022

2023

2024

2025

2026

greenLicense: OUP Standard Publication Reuse

repositoryhttps://www.ncbi.nlm.nih.gov/pmc/articles/8651247

journalhttps://doi.org/10.1093/jpp/rgab133

repositoryhttps://pubmed.ncbi.nlm.nih.gov/34473289

https://dx.doi.org/10.1093/jpp/rgab133

Fields of Study

Metabolism, Diabetes, and CancerPhytochemicals and Antioxidant ActivitiesEstrogen and related hormone effects0301 basic medicine0303 health sciences03 medical and health sciencesAMP-Activated Protein KinasesAnimalsAntineoplastic Agents, PhytogenicCatechinCell Line, TumorCell ProliferationDoxorubicinFemaleGene Expression Regulation, NeoplasticHumansMammary Glands, HumanMice, Inbred BALB CPhosphorylationPhytotherapyPlant ExtractsProto-Oncogene Proteins c-aktSignal TransductionTOR Serine-Threonine KinasesTriple Negative Breast NeoplasmsMice

MeSH Terms

AnimalsAntineoplastic Agents, PhytogenicCatechinDoxorubicinFemaleHumansPhytotherapyMice, Inbred BALB CPhosphorylationPlant ExtractsSignal TransductionGene Expression Regulation, NeoplasticMammary Glands, HumanCell Line, TumorCell ProliferationProto-Oncogene Proteins c-aktMiceAMP-Activated Protein KinasesTOR Serine-Threonine KinasesTriple Negative Breast Neoplasms

Keywords

AMPKTriple-negative breast cancerProtein kinase BPI3K/AKT/mTOR pathwayCancer researchDoxorubicinEstrogen receptorCell growthPharmacologyBreast cancerProtein kinase ABiologyChemistryCancerPhosphorylationInternal medicineSignal transductionMedicineCell biologyChemotherapyBiochemistryMammary glandSurvivalEpicatechintumourMice, Inbred BALB CPlant ExtractsTOR Serine-Threonine KinasesTriple Negative Breast NeoplasmsAMP-Activated Protein KinasesAntineoplastic Agents, PhytogenicCatechinGene Expression Regulation, NeoplasticMiceCell Line, TumorAnimalsHumansFemaleMammary Glands, HumanProto-Oncogene Proteins c-aktCell ProliferationPhytotherapy

Sustainable Development Goals

SDG 3: 3. Good healthSDG 0: Good health and well-being